{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:14:40Z","timestamp":1787170480064,"version":"build-2736575974"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2007,7,25]],"date-time":"2007-07-25T00:00:00Z","timestamp":1185321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0000652","type":"journal-article","created":{"date-parts":[[2007,7,24]],"date-time":"2007-07-24T20:00:18Z","timestamp":1185307218000},"page":"e652","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Heterologous Amyloid Seeding: Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease"],"prefix":"10.1371","volume":"2","author":[{"given":"L\u00e9titia","family":"Jean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdessamad","family":"Tahiri-Alaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Vaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2007,7,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer&apos;s amyloid \u03b2-peptide.","volume":"8","author":"C Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ncb1104-1054","article-title":"Cell biology of protein misfolding: the examples of Alzheimer&apos;s and Parkinson&apos;s diseases.","volume":"6","author":"DJ Selkoe","year":"2004","journal-title":"Nat Cell Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1059946","article-title":"Metabolic regulation of brain A\u03b2 by neprilysin.","volume":"292","author":"N Iwata","year":"2001","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0968-0004(01)01876-X","article-title":"Insulin-degrading enzyme: embarking on amyloid destruction.","volume":"26","author":"IV Kurochkin","year":"2001","journal-title":"Trends Biochem Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid \u03b2-protein, and the \u03b2-amyloid precursor protein intracellular domain in vivo.","volume":"100","author":"W Farris","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of \u03b2-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death.","volume":"40","author":"MA Leissring","year":"2003","journal-title":"Neuron"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1073\/pnas.1031520100","article-title":"Amyloid-\u03b2 peptide levels in brain are inversely correlated with insulysin activity levels in vivo.","volume":"100","author":"BC Miller","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1126\/science.290.5500.2302","article-title":"Evidence for genetic linkage of Alzheimer&apos;s disease to chromosome 10q.","volume":"290","author":"L Bertram","year":"2000","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2002.00855.x","article-title":"\u03b2-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?","volume":"81","author":"JA Carson","year":"2002","journal-title":"J Neurochem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","article-title":"Neurons regulate extracellular levels of amyloid \u03b2-protein via proteolysis by insulin-degrading enzyme.","volume":"20","author":"K Vekrellis","year":"2000","journal-title":"J Neurosci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3940(03)00898-X","article-title":"Human neprilysin is capable of degrading amyloid \u03b2 peptide not only in the monomeric form but also the pathological oligomeric form.","volume":"350","author":"H Kanemitsu","year":"2003","journal-title":"Neurosci Lett"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ana.410220603","article-title":"Anatomy of cholinesterase inhibition in Alzheimer&apos;s disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.","volume":"22","author":"MM Mesulam","year":"1987","journal-title":"Ann Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(89)90419-8","article-title":"Special properties of cholinesterases in the cerebral cortex of Alzheimer&apos;s disease.","volume":"498","author":"C Geula","year":"1989","journal-title":"Brain Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ana.410420613","article-title":"Butyrylcholinesterase in the life cycle of amyloid plaques.","volume":"42","author":"AL Guillozet","year":"1997","journal-title":"Ann Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0196-9781(02)00070-0","article-title":"Senile plaque composition and posttranslational modification of amyloid-\u03b2 peptide and associated proteins.","volume":"23","author":"CS Atwood","year":"2002","journal-title":"Peptides"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410340312","article-title":"Neurological cholinesterases in the normal brain and in Alzheimer&apos;s disease: relationship to plaques, tangles, and patterns of selective vulnerability.","volume":"34","author":"CI Wright","year":"1993","journal-title":"Ann Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1046\/j.1471-4159.1999.721600.x","article-title":"Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer&apos;s disease.","volume":"72","author":"J Saez-Valero","year":"1999","journal-title":"J Neurochem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.1073\/pnas.131152998","article-title":"Phenserine regulates translation of \u03b2-amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.","volume":"98","author":"KT Shaw","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s007020200089","article-title":"Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer&apos;s disease by rivastigmine: correlation with cognitive benefit.","volume":"109","author":"E Giacobini","year":"2002","journal-title":"J Neural Transm"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","article-title":"Changes in brain cholinesterases in senile dementia of Alzheimer type.","volume":"4","author":"EK Perry","year":"1978","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0306-4522(01)00613-3","article-title":"Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine.","volume":"110","author":"MM Mesulam","year":"2002","journal-title":"Neuroscience"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1523\/JNEUROSCI.18-09-03213.1998","article-title":"Stable complexes involving acetylcholinesterase and amyloid-\u03b2 peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer&apos;s fibrils.","volume":"18","author":"A Alvarez","year":"1998","journal-title":"J Neurosci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/1567205054367847","article-title":"Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic mice.","volume":"2","author":"TM Rees","year":"2005","journal-title":"Curr Alzheimer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.biochem.66.1.385","article-title":"Models of amyloid seeding in Alzheimer&apos;s disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.","volume":"66","author":"JD Harper","year":"1997","journal-title":"Annu Rev Biochem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1432-1327.1999.00957.x","article-title":"Interactions of Alzheimer amyloid-\u03b2 peptides with glycosaminoglycans effects on fibril nucleation and growth.","volume":"266","author":"J McLaurin","year":"1999","journal-title":"Eur J Biochem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"18495","DOI":"10.1074\/jbc.M906994199","article-title":"Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid \u03b2 peptide and inhibit A\u03b2-induced toxicity.","volume":"275","author":"J McLaurin","year":"2000","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"30370","DOI":"10.1074\/jbc.274.43.30370","article-title":"Conformational flexibility of the acetylcholinesterase tetramer suggested by x-ray crystallography.","volume":"274","author":"Y Bourne","year":"1999","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"10863","DOI":"10.1021\/bi034768i","article-title":"The intact human acetylcholinesterase C-terminal oligomerization domain is \u03b1-helical in situ and in isolation, but a shorter fragment forms \u03b2-sheet-rich amyloid fibrils and protofibrillar oligomers.","volume":"42","author":"MG Cottingham","year":"2003","journal-title":"Biochemistry"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1038\/sj.emboj.7600425","article-title":"The synaptic acetylcholinesterase tetramer assembles around a polyproline II helix.","volume":"23","author":"H Dvir","year":"2004","journal-title":"Embo J"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1110\/ps.04790604","article-title":"Detecting hidden sequence propensity for amyloid fibril formation.","volume":"13","author":"S Yoon","year":"2004","journal-title":"Protein Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"13539","DOI":"10.1021\/bi0260334","article-title":"Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer&apos;s amyloid-\u03b2 peptide.","volume":"41","author":"MG Cottingham","year":"2002","journal-title":"Biochemistry"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000065054","article-title":"The origin of the molecular diversity and functional anchoring of cholinesterases.","volume":"11","author":"J Massoulie","year":"2002","journal-title":"Neurosignals"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1046\/j.1471-4159.1994.63041446.x","article-title":"Characterization of salt-soluble forms of acetylcholinesterase from bovine brain.","volume":"63","author":"J Liao","year":"1994","journal-title":"J Neurochem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0197-4580(02)00230-0","article-title":"Acetylcholinesterase promotes \u03b2-amyloid plaques in cerebral cortex.","volume":"24","author":"T Rees","year":"2003","journal-title":"Neurobiol Aging"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1074\/jbc.272.10.6641","article-title":"Degradation of amyloid \u03b2-protein by a metalloprotease secreted by microglia and other neural and non-neural cells.","volume":"272","author":"WQ Qiu","year":"1997","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","article-title":"Insulin-degrading enzyme regulates extracellular levels of amyloid \u03b2-protein by degradation.","volume":"273","author":"WQ Qiu","year":"1998","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/abio.2000.4880","article-title":"Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set.","volume":"287","author":"N Sreerama","year":"2000","journal-title":"Anal Biochem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"28551","DOI":"10.1016\/S0021-9258(19)61939-3","article-title":"Surfactant properties of Alzheimer&apos;s A\u03b2 peptides and the mechanism of amyloid aggregation.","volume":"269","author":"B Soreghan","year":"1994","journal-title":"J Biol Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/labinvest.3700054","article-title":"Rapid method for measurement of surface tension in multiwell plates.","volume":"84","author":"MG Cottingham","year":"2004","journal-title":"Lab Invest"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.0602922103","article-title":"Butyrylcholinesterase attenuates amyloid fibril formation in vitro.","volume":"103","author":"S Diamant","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/jsbi.1997.3859","article-title":"The toxicity of the Alzheimer&apos;s \u03b2-amyloid peptide correlates with a distinct fiber morphology.","volume":"119","author":"B Seilheimer","year":"1997","journal-title":"J Struct Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"\u03b1-synuclein, especially the Parkinson&apos;s disease-associated mutants, forms pore-like annular and tubular protofibrils.","volume":"322","author":"HA Lashuel","year":"2002","journal-title":"J Mol Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-2836(03)00927-6","article-title":"Mixtures of wild-type and a pathogenic (E22G) form of A\u03b240 in vitro accumulate protofibrils, including amyloid pores.","volume":"332","author":"HA Lashuel","year":"2003","journal-title":"J Mol Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-\u03b2-peptides into Alzheimer&apos;s fibrils: possible role of the peripheral site of the enzyme.","volume":"16","author":"NC Inestrosa","year":"1996","journal-title":"Neuron"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nature05143","article-title":"Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism.","volume":"443","author":"Y Shen","year":"2006","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1074\/jbc.M008702200","article-title":"Analysis of the subsite specificity of rat insulysin using fluorogenic peptide substrates.","volume":"276","author":"ES Song","year":"2001","journal-title":"J Biol Chem"},{"key":"ref47","first-page":"608","article-title":"Insulin degradation: progress and potential.","volume":"19","author":"WC Duckworth","year":"1998","journal-title":"Endocr Rev"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1007527721160","article-title":"Degradation of soluble amyloid \u03b2-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.","volume":"25","author":"A Perez","year":"2000","journal-title":"Neurochem Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.neurobiolaging.2004.06.013","article-title":"Age- and region-dependent alterations in A\u03b2-degrading enzymes: implications for A\u03b2-induced disorders.","volume":"26","author":"A Caccamo","year":"2005","journal-title":"Neurobiol Aging"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3940(00)01675-X","article-title":"Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of \u03b2-amyloid peptide.","volume":"297","author":"K Yasojima","year":"2001","journal-title":"Neurosci Lett"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0959-440X(97)80007-3","article-title":"The prion folding problem.","volume":"7","author":"PM Harrison","year":"1997","journal-title":"Curr Opin Struct Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1110\/ps.9.10.1960","article-title":"Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy.","volume":"9","author":"M Bouchard","year":"2000","journal-title":"Protein Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1006\/jmbi.2001.4970","article-title":"Identification and characterization of key kinetic intermediates in amyloid \u03b2-protein fibrillogenesis.","volume":"312","author":"MD Kirkitadze","year":"2001","journal-title":"J Mol Biol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"12945","DOI":"10.1074\/jbc.M010402200","article-title":"Prediction of amyloid fibril-forming proteins.","volume":"276","author":"Y Kallberg","year":"2001","journal-title":"J Biol Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1097-0282(1998)47:1<83::AID-BIP9>3.0.CO;2-T","article-title":"Design of peptides undergoing self-catalytic \u03b1-to-\u03b2 transition and amyloidogenesis.","volume":"47","author":"H Mihara","year":"1998","journal-title":"Biopolymers"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jmb.2004.06.020","article-title":"Modulation of S6 fibrillation by unfolding rates and gatekeeper residues.","volume":"341","author":"JS Pedersen","year":"2004","journal-title":"J Mol Biol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"46363","DOI":"10.1074\/jbc.C400260200","article-title":"Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases.","volume":"279","author":"R Kayed","year":"2004","journal-title":"J Biol Chem"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00005072-199409000-00003","article-title":"Alzheimer&apos;s disease: a central role for amyloid.","volume":"53","author":"DJ Selkoe","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","article-title":"Oligomeric and fibrillar species of amyloid-\u03b2 peptides differentially affect neuronal viability.","volume":"277","author":"KN Dahlgren","year":"2002","journal-title":"J Biol Chem"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid \u03b2 peptide concentration as a predictor of synaptic change in Alzheimer&apos;s disease.","volume":"155","author":"LF Lue","year":"1999","journal-title":"Am J Pathol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of A\u03b2 amyloid as a determinant of severity of neurodegeneration in Alzheimer&apos;s disease.","volume":"46","author":"CA McLean","year":"1999","journal-title":"Ann Neurol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"A\u03b2 oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer&apos;s disease.","volume":"27","author":"PN Lacor","year":"2007","journal-title":"J Neurosci"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/jmbi.2001.4593","article-title":"Identification of a novel human islet amyloid polypeptide \u03b2-sheet domain and factors influencing fibrillogenesis.","volume":"308","author":"ET Jaikaran","year":"2001","journal-title":"J Mol Biol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/ar000214l","article-title":"Rapid photochemical cross-linking\u2013a new tool for studies of metastable, amyloidogenic protein assemblies.","volume":"37","author":"G Bitan","year":"2004","journal-title":"Acc Chem Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0000652","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T05:42:26Z","timestamp":1629438146000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0000652"}},"subtitle":[],"editor":[{"given":"Joseph El","family":"Khoury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,7,25]]},"references-count":64,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2007,7,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0000652","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,25]]}}}